Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC11543 Cesium chloride Cesium chloride  Chemical Structure
  3. GC68857 Cetrelimab

    JNJ 63723283; JNJ 3283

    Cetrelimab (JNJ 63723283; JNJ 3283) is a humanized IgG4 monoclonal antibody that targets PD-1. Cetrelimab has a Kd of 1.72 nM for binding to PD-1 (HEK293 cells). As such, Cetrelimab blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2 (with IC50 values of 111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab also stimulates peripheral T cells, increases cytokine levels (IFN-gamma, IL-2, TNF-alpha), and inhibits tumor growth in vivo.

    Cetrelimab  Chemical Structure
  4. GC11710 CFM 4 CFM 4 is a potent small molecular antagonist of CARP-1/APC-2 binding. CFM 4 prevents CARP-1 binding with APC-2, causes G2M cell cycle arrest, and induces apoptosis with an IC50 range of 10-15 μM. CFM 4 also suppresses growth of drug-resistant human breast cancer cells. CFM 4  Chemical Structure
  5. GC35668 CG-200745

    CG-200745

    CG-200745 (CG-200745) is an orally active, potent pan-HDAC inhibitor which has the hydroxamic acid moiety to bind zinc at the bottom of catalytic pocket. CG-200745 inhibits deacetylation of histone H3 and tubulin. CG-200745 induces the accumulation of p53, promotes p53-dependent transactivation, and enhances the expression of MDM2 and p21 (Waf1/Cip1) proteins. CG-200745 enhances the sensitivity of Gemcitabine-resistant cells to Gemcitabine and 5-Fluorouracil (5-FU; ). CG-200745 induces apoptosis and has anti-tumour effects. CG-200745  Chemical Structure
  6. GC10666 CGP 57380

    MNK1 Inhibitor

    MNK1 inhibitor, specific and selective CGP 57380  Chemical Structure
  7. GC43234 Chaetoglobosin A Chaetoglobosin A is a mycotoxic cytochalasin that was first isolated from the marine-derived endophytic fungus C. Chaetoglobosin A  Chemical Structure
  8. GC18536 Chartreusin

    Antibiotic X 465A, Lambdamycin, NSC 5159

    Chartreusin is an antibiotic originally isolated from S. Chartreusin  Chemical Structure
  9. GN10463 Chelerythrine Chelerythrine  Chemical Structure
  10. GC13065 Chelerythrine Chloride

    Broussonpapyrine chloride, NSC 646662

    Potent inhibitor of PKC and Bcl-xL Chelerythrine Chloride  Chemical Structure
  11. GC31886 Chelidonic acid

    NSC 3979

    A pyran with diverse biological activities Chelidonic acid  Chemical Structure
  12. GC40878 Chelidonine Chelidonine is a benzophenanthridine alkaloid that has been isolated from C. Chelidonine  Chemical Structure
  13. GC43236 Chevalone B Chevalone B is a meroterpenoid originally isolated from the fungus E. Chevalone B  Chemical Structure
  14. GC43237 Chevalone C Chevalone C is a meroterpenoid fungal metabolite originally isolated from E. Chevalone C  Chemical Structure
  15. GC64993 Chicoric acid

    L-Chicoric Acid, Dicaffeoyltartaric Acid, NSC 99173

    Chicoric acid (Cichoric acid), an orally active dicaffeyltartaric acid, induces reactive oxygen species (ROS) generation. Chicoric acid  Chemical Structure
  16. GC15739 CHIR-124 Chk1 inhibitor,novel and potent CHIR-124  Chemical Structure
  17. GC43239 Chk2 Inhibitor

    SC-203885

    Chk2 Inhibitor (compound 1) is a potent and selective inhibitor of checkpoint kinase 2 (Chk2), with IC50s of 13.5 nM and 220.4 nM for Chk2 and Chk1, respectively. Chk2 Inhibitor can elicit a strong ataxia telangiectasia mutated (ATM)-dependent Chk2-mediated radioprotection effect. Chk2 Inhibitor  Chemical Structure
  18. GC45717 Chlamydocin An HDAC inhibitor Chlamydocin  Chemical Structure
  19. GC17969 CHM 1

    NSC 656158

    An inhibitor of tubulin polymerization CHM 1  Chemical Structure
  20. GC35682 CHMFL-ABL/KIT-155

    CHMFL-ABL-KIT-155

    CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; compound 34) is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor (IC50s of 46 nM and 75 nM, respectively), and it also presents significant inhibitory activities to BLK (IC50=81 nM), CSF1R (IC50=227 nM), DDR1 (IC50=116 nM), DDR2 (IC50=325 nM), LCK (IC50=12 nM) and PDGFRβ (IC50=80 nM) kinases. CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155) arrests cell cycle progression and induces apoptosis. CHMFL-ABL/KIT-155  Chemical Structure
  21. GC64028 Chrysosplenol D Chrysosplenol D is a methoxy flavonoid that induces ERK1/2-mediated apoptosis in triple negative human breast cancer cells. Chrysosplenol D  Chemical Structure
  22. GC13408 CI994 (Tacedinaline)

    N-Acetyldinaline, Goe 5549, PD 123654, Tacedinaline

    An inhibitor of HDAC1, -2, and -3 CI994 (Tacedinaline)  Chemical Structure
  23. GC13589 CID 755673 PKD inhibitor CID 755673  Chemical Structure
  24. GC19436 CID-5721353 CID5721353 is an inhibitor of BCL6 with an IC50 value of 212 μM, which corresponds to a Ki of 147 μM. CID-5721353  Chemical Structure
  25. GC32997 Cinchonine ((8R,9S)-Cinchonine) Cinchonine ((8R,9S)-Cinchonine) is a natural compound present in Cinchona bark. Cinchonine ((8R,9S)-Cinchonine) activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells. Cinchonine ((8R,9S)-Cinchonine)  Chemical Structure
  26. GC60708 Cinchonine hydrochloride Cinchonine hydrochloride ((8R,9S)-Cinchonine hydrochloride) is a natural alkaloid present in Cinchona bark, with antimalarial activity. Cinchonine hydrochloride activates endoplasmic reticulum (ER) stress-induced apoptosis in human liver cancer cells. Cinchonine hydrochloride  Chemical Structure
  27. GC52269 Cinnabarinic Acid-d4 An internal standard for the quantification of cinnabarinic acid Cinnabarinic Acid-d4  Chemical Structure
  28. GC40986 Cinnamamide

    NSC 32953

    Cinnamamide is an amide form of of trans-cinnamic acid and a metabolite of Streptomyces. Cinnamamide  Chemical Structure
  29. GN10189 Cinobufagin

    NSC 90325

    Cinobufagin  Chemical Structure
  30. GC70418 Cipepofol Cipepofol (Ciprofol), a novel 2,6-disubstituted phenol derivative, is a positive allosteric modulator and direct agonist of the GABAA receptor. Cipepofol  Chemical Structure
  31. GC11908 Cisplatin

    CDDP

    Cisplatin is one of the best and first metal-based chemotherapeutic drugs, which is used for wide range of solid cancers such as testicular, ovarian, bladder, lung, cervical, head and neck cancer, gastric cancer and some other cancers. Cisplatin  Chemical Structure
  32. GC17491 CITCO

    Constitutive androstane receptor (CAR) agonist

    CITCO  Chemical Structure
  33. GC35703 Citicoline Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline  Chemical Structure
  34. GC31186 Citicoline sodium salt

    Cytidine 5'diphosphocholine, Flussorex, Gerolin, Logan, Neurotron, Sinkron

    Citicoline sodium salt salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects. Citicoline sodium salt  Chemical Structure
  35. GC43273 Citreoindole Citreoindole is a diketopiperazine metabolite isolated from a hybrid cell fusion of two strains of P. Citreoindole  Chemical Structure
  36. GC41514 Citreoviridin Citreoviridin is a mycotoxin isolated from several Penicillium species that has been shown to inhibit the mitochondrial ATP synthetase system. Citreoviridin  Chemical Structure
  37. GC14203 Citric acid

    Commonly used laboratory reagent

    Citric acid  Chemical Structure
  38. GC68873 Citric acid trisodium

    Citric acid trisodium is a natural preservative and food acidifier. It induces apoptosis and cell cycle arrest at the G2/M phase and S phase. Citric acid trisodium causes oxidative damage to the liver by reducing antioxidant enzyme activity. It also causes nephrotoxicity in mice.

    Citric acid trisodium  Chemical Structure
  39. GC68051 Citric acid-d4 Citric acid-d4  Chemical Structure
  40. GC16661 Citrinin

    NSC 186

    Citrinin is a mycotoxin with multiple biological activities produced by several fungal strains of the genera Penicillium, Aspergillus, and Monascus. Citrinin  Chemical Structure
  41. GC43274 Citromycetin

    NSC 53584

    Citromycetin is a fungal metabolite originally isolated from P. Citromycetin  Chemical Structure
  42. GC63393 Citronellyl acetate Citronellyl acetate is a monoterpene product of the secondary metabolism of plants, with antinociceptive activity. Citronellyl acetate  Chemical Structure
  43. GC52367 Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide

    Biotin-GQGKS(Cit)L(Cit)DLYEEEMRELRRQ, Biotin-GQGKSXLXDLYEEEMRELRRQ (X=Citrulline), Citrullinated VIM (G146R) (R144 + R146)-biotin

    A biotinylated and citrullinated mutant vimentin peptide Citrullinated Vimentin (G146R) (R144 + R146) (139-159)-biotin Peptide  Chemical Structure
  44. GC52370 Citrullinated Vimentin (R144) (139-159)-biotin Peptide

    Biotin-GQGKS(Cit)LGDLYEEEMRELRRQ, Biotin-GQGKSXLGDLYEEEMRELRRQ (X=Citrulline), Citrullinated VIM (R144)-biotin

    A biotinylated and citrullinated vimentin peptide Citrullinated Vimentin (R144) (139-159)-biotin Peptide  Chemical Structure
  45. GN10219 Ciwujianoside-B Ciwujianoside-B  Chemical Structure
  46. GC64649 Cjoc42 Cjoc42 is a compound capable of binding to gankyrin. Cjoc42 inhibits gankyrin activity in a dose-dependent manner. Cjoc42 prevents the decrease in p53 protein levels normally associated with high amounts of gankyrin. Cjoc42 restores p53-dependent transcription and sensitivity to DNA damage. Cjoc42  Chemical Structure
  47. GC39485 CK2/ERK8-IN-1 A dual inhibitor of CK2 and ERK8 CK2/ERK8-IN-1  Chemical Structure
  48. GC49556 Cl-Necrostatin-1

    7-Cl-Nec-1, 7-Cl-Necrostatin-1, Nec-1f

    A RIPK1 inhibitor Cl-Necrostatin-1  Chemical Structure
  49. GC47098 CL2-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38 CL2-SN-38 (dichloroacetic acid salt)  Chemical Structure
  50. GC60714 CL2A-SN-38 An antibody-drug conjugate containing SN-38 CL2A-SN-38  Chemical Structure
  51. GC52469 CL2A-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38 CL2A-SN-38 (dichloroacetic acid salt)  Chemical Structure
  52. GC10509 Cladribine

    2-Chlorodeoxyadenosine, Jk 6251, NSC 105014, RWJ 26251

    Apoptosis inducer in CLL cells Cladribine  Chemical Structure
  53. GC68882 Cleomiscosin A

    Cleomiscosin A is a coumarin lignan produced by Macaranga adenantha. It has activity in inducing TNF-alpha secretion from mouse peritoneal macrophages.

    Cleomiscosin A  Chemical Structure
  54. GC60111 Clitocine Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity. Clitocine  Chemical Structure
  55. GC15219 Clofarabine

    Clolar, Evoltra

    Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase Clofarabine  Chemical Structure
  56. GC10813 Clofibric Acid

    NSC 1149

    PPAR agonist Clofibric Acid  Chemical Structure
  57. GC32587 Clofilium tosylate Clofilium tosylate, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3. Clofilium tosylate  Chemical Structure
  58. GC47105 Clonostachydiol A fungal metabolite with anticancer and anthelmintic activities Clonostachydiol  Chemical Structure
  59. GC12367 CM-272 CM-272 is a first-in-class reversible dual inhibitor against G9a and DNMTs with IC50 values of 8 nM and 382 nM, respectively [1]. CM-272  Chemical Structure
  60. GC62347 CMC2.24

    TRB-N0224

    CMC2.24 (TRB-N0224), an orally active tricarbonylmethane agent, is effective against pancreatic tumor in mice by inhibiting Ras activation and its downstream effector ERK1/2 pathway. CMC2.24  Chemical Structure
  61. GC61567 CMLD-2 CMLD-2, an inhibitor of HuR-ARE interaction, competitively binds HuR protein disrupting its interaction with adenine-uridine rich elements (ARE)-containing mRNAs (Ki=350 nM). CMLD-2 induces apoptosis exhibits antitumor activity in different cancer cells as colon, pancreatic, thyroid and lung cancer cell lines. Hu antigen R (HuR) is an RNA binding protein, can regulate target mRNAs stability and translation. CMLD-2  Chemical Structure
  62. GC49096 Cobaltic Protoporphyrin IX (chloride) An inducer of HO-1 activity Cobaltic Protoporphyrin IX (chloride)  Chemical Structure
  63. GC10033 Cobimetinib

    GDC-0973, RG-7420, XL518

    A potent, orally available MEK1 inhibitor Cobimetinib  Chemical Structure
  64. GC43297 Coenzyme Q2

    CoQ2, Ubiquinone-2, Ubiquinone Q2

    Coenzyme Q10 is a component of the electron transport chain and participates in aerobic cellular respiration, generating energy in the form of ATP. Coenzyme Q2  Chemical Structure
  65. GC62192 COG1410 COG1410 is an apolipoprotein E-derived peptide. COG1410  Chemical Structure
  66. GC40664 Colcemid

    Demecolcine, NSC 3096

    Colcemid is a cytoskeletal inhibitor that induces mitotic arrest in the G2/M phase or meiotic arrest in the vesicle rupture (GVBD) phase in mammalian cells or oocytes, respectively. Colcemid  Chemical Structure
  67. GN10123 Columbianadin

    Columbianetin

    Columbianadin  Chemical Structure
  68. GC49454 Complex 3 A fluorescent copper complex with anticancer activity Complex 3  Chemical Structure
  69. GC18572 Concanavalin A

    CConcanavalin A belongs to the concanamycins, a family of macrolide antibiotics isolated from Streptomyces diastatochromogenes that are highly active and selective inhibitors of the vacuolar proton-ATPase (v-[H+]ATPase).

    Concanavalin A  Chemical Structure
  70. GC18832 Conglobatin Conglobatin is a dimeric macrolide dilactone originally isolated from S. Conglobatin  Chemical Structure
  71. GC48483 Conglobatin B A bacterial metabolite Conglobatin B  Chemical Structure
  72. GC48497 Conglobatin C1 A bacterial metabolite Conglobatin C1  Chemical Structure
  73. GC38376 Coniferaldehyde Coniferaldehyde (Ferulaldehyde) is an effective inducer of heme oxygenase-1 (HO-1). Coniferaldehyde  Chemical Structure
  74. GC63379 Conophylline Conophylline is a vinca alkaloid extracted from leaves of a tropical plant Ervatamia microphylla. Conophylline  Chemical Structure
  75. GC16772 Cortisone acetate

    Cortisone 21-acetate, NSC 49420

    Glucocorticoid receptor agonist Cortisone acetate  Chemical Structure
  76. GC16116 Costunolide

    Costus lactone, Melampolide, NSC 106404

    A natural sesquiterpene lactone Costunolide  Chemical Structure
  77. GC15225 COTI-2 activates mutant forms of p53 COTI-2  Chemical Structure
  78. GC15840 CP 31398 dihydrochloride A p53 stabilizing agent CP 31398 dihydrochloride  Chemical Structure
  79. GC13091 CP-724714 HER2 inhibitor,potent and selective CP-724714  Chemical Structure
  80. GC14500 CPI-1189 necrosis factor (TNF) alpha inhibitor CPI-1189  Chemical Structure
  81. GC14699 CPI-203 BET bromodomain inhibitor CPI-203  Chemical Structure
  82. GC10021 CPI-360 EZH2 inhibitor CPI-360  Chemical Structure
  83. GC14921 CPI-613 An inhibitor of α-ketoglutarate dehydrogenase CPI-613  Chemical Structure
  84. GC39365 CPTH2 CPTH2 is a potent histone acetyltransferase (HAT) inhibitor. CPTH2 selectively inhibits the acetylation of histone H3 by Gcn5. CPTH2 induces apoptosis and decreases the invasiveness of a clear cell renal carcinoma (ccRCC) cell line through the inhibition of acetyltransferase p300 (KAT3B). CPTH2  Chemical Structure
  85. GC35747 Crebanine

    (–)-Crebanine

    Crebanine, an alkaloid from Stephania venosa, induces G1 arrest and apoptosis in human cancer cells. Crebanine  Chemical Structure
  86. GC34543 cRIPGBM cRIPGBM, a proapoptotic derivative of RIPGBM, a cell type-selective inducer of apoptosis in GBM cancer stem cells (CSCs) by binding to receptor-interacting protein kinase 2 (RIPK2), with an EC50 of 68 nM in GBM-1 cells. cRIPGBM  Chemical Structure
  87. GC68903 cRIPGBM chloride

    cRIPGBM chloride is an orally effective pro-apoptotic derivative that can be produced from cancer stem cells (CSC) of glioblastoma multiforme (GBM). cRIPGBM chloride induces caspase 1-dependent cell apoptosis by targeting receptor-interacting protein kinase 2 (RIPK2) through the formation of RIPK2/caspase 1 complex and inhibition of RIPK2/TAK1 (pro-survival complex) formation. In animal models, cRIPGBM chloride exhibits strong in vivo anti-tumor activity.

    cRIPGBM chloride  Chemical Structure
  88. GC13838 CRT 0066101 PKD inhibitor CRT 0066101  Chemical Structure
  89. GC35750 CRT0066101 dihydrochloride CRT0066101 dihydrochloride is a potent and specific PKD inhibitor with IC50 values of 1, 2.5 and 2 nM for PKD1, 2, and 3 respectively. CRT0066101 dihydrochloride  Chemical Structure
  90. GC45414 CRT0066854   CRT0066854  Chemical Structure
  91. GC14355 CRT5

    CRT0066051

    PKD1, PKD2, and PKD3 inhibitor CRT5  Chemical Structure
  92. GC32911 CTX1 CTX1 is a p53 activator that overcomes HdmX-mediated p53 repression. CTX1 exhibits potent anti-cancer activity in a mouse acute myeloid leukemia (AML) model system. CTX1  Chemical Structure
  93. GN10535 Cucurbitacin B

    Cuc B, NSC 49451, NSC 144154

    Cucurbitacin B  Chemical Structure
  94. GC35758 Cucurbitacin IIa Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells. Cucurbitacin IIa  Chemical Structure
  95. GN10788 Cucurbitacin IIb

    Cuc B, NSC 49451, NSC 144154

    Cucurbitacin IIb  Chemical Structure
  96. GC32781 CUDC-427 (GDC-0917)

    GDC-0917

    CUDC-427 (GDC-0917) is a potent second-generation pan-selective IAP antagonist, used for treatment of various cancers. CUDC-427 (GDC-0917)  Chemical Structure
  97. GC12115 CUDC-907

    CUDC-907

    CUDC is an orally bioavailable small molecule PI3K and HDAC dual inhibitor that acts on PI3K α And HDAC1 / 2 / 3 / 10 with IC50 of 19 nm and 1.7 nm / 5 nm / 1.8 nm / 2.8 nm. CUDC-907  Chemical Structure
  98. GC11217 CUR 61414

    G-856

    potent inhibitor of hedgehog-induced cellular activity CUR 61414  Chemical Structure
  99. GC14787 Curcumin

    Indian Saffron, Turmeric yellow

    A yellow pigment with diverse biological activities Curcumin  Chemical Structure
  100. GC40226 Curcumin-d6 Curcumin-d6 is intended for use as an internal standard for the quantification of curcumin by GC- or LC-MS. Curcumin-d6  Chemical Structure
  101. GN10521 Curcumol

    (-)-Curcumol

    Curcumol  Chemical Structure

Items 601 to 700 of 2329 total

per page
  1. 5
  2. 6
  3. 7
  4. 8
  5. 9

Set Descending Direction